The Patent Finder

Terms ending in 2031

Irm LLC

Every in-force patent on Irm LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,064,918Mesenchymal Stem Cell Differentiation
In force
 · High confidence
Novartis International Pharmaceuticals Ltd.In forceHigh confidence
US 9,580,426Compounds That Expand Hematopoietic Stem Cells
In force
 · High confidence
The Scripps Research InstituteIn forceHigh confidence
US 9,365,506Compounds and Compositions as TLR2 Agonists
In force
 · High confidence
Irm LLCIn forceHigh confidence
US 9,314,464Compounds and Compositions as Protein Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 8,557,801Compounds and Compositions Useful for the Treatment of Parasitic Diseases
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 8,808,703Compounds (Cystein Based Lipopeptides) and Compositions as TLR2 Agonists Used for Treating Infections, Inflammations, Respiratory Diseases Etc.
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,098,949Adsorption of Immunopotentiators to Insoluble Metal Salts
In force
 · High confidence
GlaxoSmithKline Biologicals S.A.In forceHigh confidence
US 9,315,530Adsorption of Immunopotentiators to Insoluble Metal Salts
In force
 · High confidence
GlaxoSmithKline Biologicals S.A.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited